Megestrol acetate concentrated suspension 110 mg/mL

DRUG2 trials

Sponsors

Par Pharmaceutical, Inc.

Conditions

AnorexiaCachexiaWeight Loss

Phase 3

Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension

TerminatedNCT00637806

Par Pharmaceutical, Inc.Anorexia, Cachexia, Weight Loss

Start: 2006-06-30End: 2006-09-30Updated: 2016-05-02

Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients

TerminatedNCT00637728

Par Pharmaceutical, Inc.Anorexia, Cachexia, Weight Loss

Start: 2006-06-30End: 2006-09-30Updated: 2016-06-23